Performance of high-risk HPV DNA testing with HPV 16/18 genotyping in the triage of women with NILM cytology: A national multicenter prospective cohort study in China

被引:0
|
作者
Wang, H. [1 ,2 ]
Liu, Y. [1 ,2 ]
Xu, H. [1 ,2 ]
Chen, P. [1 ,2 ]
Sun, X. [1 ,2 ]
Li, M. [1 ,2 ]
Li, P. [1 ,2 ]
Li, K. [1 ,2 ]
Zheng, L. [1 ,2 ]
Zhang, S. [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
000928
引用
收藏
页码:38 / 39
页数:2
相关论文
共 50 条
  • [41] Evaluation of p16/Ki-67 dual stain, cytology, and HPV16/18 genotyping for triage of HPV-positive women in a large screening population
    Wentzensen, Nicolas A.
    Fetterman, Barbara
    Bremer, Renee
    Castle, Philip
    Tokugawa, Diane
    Poitras, Nancy
    Hosfield, Elizabeth
    Lorey, Thomas
    Schiffman, Mark
    Kinney, Walter
    CANCER RESEARCH, 2017, 77
  • [42] Can high-risk HPV DNA testing be justified in the triage and management of ASCUS/LGSIL patients?
    Ledet, S
    Ramzy, I
    Irwin, J
    Rainer, A
    Younes, P
    Apostol, J
    Mody, DR
    MODERN PATHOLOGY, 1998, 11 (01) : 40A - 40A
  • [43] Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology
    Bogani, Giorgio
    Taverna, Francesca
    Lombardo, Claudia
    Borghi, Chiara
    Martinelli, Fabio
    Signorelli, Mauro
    Maggiore, Umberto Leone Roberti
    Chiappa, Valentina
    Scaffa, Cono
    Ditto, Antonino
    Lorusso, Domenica
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 138 (01) : 62 - 68
  • [44] The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology A Large Retrospective Study From Southwest China
    Jiang, Wei
    Austin, R. Marshall
    Zhang, Huina
    He, Yanmei
    Xu, Lian
    Wu, Xiuli
    Kuang, Wei
    Tong, Lingling
    Li, Lei
    Zhao, Chengquan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (04) : 472 - 479
  • [45] HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
    Stoler, Mark H.
    Wright, Thomas C., Jr.
    Parvu, Valentin
    Yanson, Karen
    Eckert, Karen
    Kodsi, Salma
    Cooper, Charles
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 151 (04) : 433 - 442
  • [46] High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand
    Khunamornpong, Surapan
    Settakorn, Jongkolnee
    Sukpan, Kornkanok
    Srisomboon, Jatupol
    Intaraphet, Suthida
    Siriaunkgul, Sumalee
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (01) : 135 - 143
  • [47] Prevalence of High-risk HPV in Postmenopausal Women with Benign Cervical Cytology - A Population-based Cohort Study
    Asciutto, Katrin Christine
    Forslund, Ola
    Borgfeldt, Christer
    ANTICANCER RESEARCH, 2018, 38 (07) : 4221 - 4228
  • [48] High-risk HPV-16 DNA testing after treatment for carcinoma cervix
    Kashyap, Veena
    Hedau, Suresh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (04) : 594 - U208
  • [49] Age-Stratified Performance of the Cervista HPV 16/18 Genotyping Test in Women with ASC-US Cytology
    Einstein, Mark H.
    Garcia, Francisco A. R.
    Mitchell, Amy L.
    Day, Stephen P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (06) : 1185 - 1189
  • [50] Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China
    Tao, Xiang
    Austin, R. Marshall
    Yu, Ting
    Zhong, Fangfang
    Zhou, Xianrong
    Cong, Qing
    Sui, Long
    Zhao, Chengquan
    CANCER CYTOPATHOLOGY, 2022, 130 (04) : 248 - 258